BlinkLab Limited (ASX:BB1)
AI diagnostic smartphone platform
- B2B
About BlinkLab Limited (ASX:BB1)
Develops a smartphone-based AI and machine learning diagnostic platform for autism, ADHD, schizophrenia, and other neurodevelopmental conditions, with a focus on early child screening.
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- Delft, Zuid-Holland, Netherlands
- Founded
- 2021
- Revenue
- $9.6M – $75.7MTamtam estimate
- Website
- blinklab.org
BlinkLab Limited (ASX:BB1) at a glance
BlinkLab Limited (ASX:BB1) is a B2B company in the Biotechnology Research industry, headquartered in Delft, Zuid-Holland, Netherlands.
BlinkLab Limited (ASX:BB1) was founded in 2021.
BlinkLab Limited (ASX:BB1) has 11–50 employees.
BlinkLab Limited (ASX:BB1)'s revenue is $9.6M – $75.7M (Tamtam estimate).
Selling to companies like BlinkLab Limited (ASX:BB1)?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies